Neovacs SA (FR:ALNEV) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neovacs SA has terminated its bond financing agreement with Pharnext due to default cases announced by Pharnext, leading to an early repayment request of approximately €22 million. If Pharnext fails to repay, the trustee can seize Pharnext’s intellectual property, bank accounts, and insurance claims. This situation could potentially affect Neovacs’ share price due to market sales of shares resulting from this financial arrangement.
For further insights into FR:ALNEV stock, check out TipRanks’ Stock Analysis page.